Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
A strange case of cardiotoxicity from antiblastic treatment: a high price to pay.
Anno:
2024
Introduction. Cardiovascular diseases and cancer represent the two main public health problems in the west. Targeted oncological therapies extend the average life expectancy of patients, but also cause acute or chronic cardiovascular toxicity. Case report. A 58-year-old woman without cardiovascular risk factors comes to the Emergency Department for oppressive…
PAPILLARY FIBROELASTOMA: AN UNUSUAL CAUSE OF TRANSIENT ISCHEMIC ATTACK
Anno:
2024
Papillary fibroelastomas (PFEs) are small, avascular benign tumors. Despite that, PFEs could lead to important clinical consequences such as transient ischemic attack and myocardial infarction. A 65-year-old female patient was admitted to our ER presenting a transient ischemic attack characterized by retrograde amnesia lasting about an hour. She had…
Cardiovascular toxicity in metastatic prostate cancer treatment: balancing risks, treating consequences
Anno:
2024
INTRODUCTION Enzalutamide inhibits the receptor of androgen hormones. It is administered for treating metastasized prostate cancer. Enzalutamide is known to have a cardiotoxic effect. CASE REPORT A 76 year-old man on-treatment for hypertension and overall good health underwent radical prostatectomy and bilateral ileo-obturator lymphadenectomy in 2021 for prostate cancer….
Entrectinib-induced acute right heart failure in a patient with metastatic lung adenocarcinoma
Anno:
2024
We report a case report of a 45-year-old woman with a recent diagnosis of stage IV lung adenocarcinoma (PDL1 60%) with brain metastases, who started entrectinib 600 mg orally once daily. Four days after entrectinib initiation, the patient activated the emergency medical services for acute onset of marked fatigue…